|
| Sample Newsletters | MarketPlace AIS Products & Services |
|
With a popular new president and a Democratic-controlled Congress preparing to assume power next month, major changes in pharmaceutical regulation and legislation are highly likely. With the prospect of sudden, dynamic change, unprecedented new challenges and opportunities could soon exist for your organization. Join us on Dec. 17 and hear two leading pharmaceutical industry analysts assess the chances of dramatic impact on all links in the drug chain, from manufacturers, PBMs and specialty pharmacies to health plans, physicians and patients. You’ll get insider perspectives on questions such as:
Team-Wide Training at Its Best (and most cost- and time-efficient). Gather your management team around the table on December 17 for one low single-participant price. And photocopy for each of them as many copies of our printed materials as you need. Managers throughout your organization will learn about major changes ahead that could impact the pharmaceutical regulatory landscape.
MARC SAMUELS, J.D., is a partner with Washington, D.C.-based HillCo Partners, a strategic advisory firm focused on providing timely, strategic advice about reimbursement policy risks and opportunities presented in the current public and private health care environment. He provides support to product management and corporate reimbursement and policy resources beginning when a product is in Phase II clinical research through the product life cycle to patent expiration. Much of his time is spent educating and advising clients planning significant new initiatives in the regulatory arena, and providing independent expert opinion on policy and business issues in health care, helping to explore the ramifications of various public and reimbursement policy options. Mr. Samuels also works with the investment community to identify potentially material changes in the regulatory and reimbursement environments faced by health care companies and to assess problems and opportunities in potential health care investments before the beginning of active due diligence. He and his partners have each played pivotal roles in developing policy and affecting the regulatory agenda on some of the most critical coverage and payment policy issues affected by Medicare and Medicaid, including age-related macular degeneration, left ventricular assist devices, radiopharmaceuticals, obesity as an illness, anti-cancer therapies, intravenous immunoglobulin, home infusion, average sales price and average manufacturer price reform, and coverage of vaccines, oral antiemetics, and vitamin-enhanced products under Medicare Part D. Mr. Samuels attended the University of Texas School of Law, Yale School of Medicine and the University of Michigan. He is a board member of the University of Houston Health Law & Policy Institute. BONNIE WASHINGTON is a vice president with Avalere Health LLC. She provides clients with strategic policy advice on a wide range of issues including Medicare policy development, health reform and commercial strategy. Ms. Washington has particular expertise in the Medicare prescription drug benefit, Medicare Advantage, and pharmaceutical and health plan issues. Prior to joining Avalere, she led health policy development efforts for Novartis Pharmaceuticals Corp. and Ovations, a UnitedHealth Group company. Before her industry experience, Ms. Washington led the Office of Legislation at CMS. Specifically, she advised and represented the CMS administrator on legislation and policy related to Medicare, Medicaid and the State Children’s Health Insurance Program (SCHIP). She also represented the administration before members of Congress and congressional staff. Previously, Ms. Washington served as an analyst with the Office of Management and Budget, advising OMB and White House policy officials on Medicaid and SCHIP policy options. She holds a B.A. from Loyola College in Maryland and an M.Sc. from the London School of Economics. Moderator: Angela Maas, managing editor of AIS’s Specialty Pharmacy News.
Government affairs and compliance directors; strategic planners; product development, contracting and marketing executives; pharmacy, clinical services and medical directors; and financial and operations executives at
1. Register above (or call 800-521-4323 to register). 2. When you register, you will receive a confirmation by e-mail from AISconferences@aispub.com, with a toll-free number and password that will connect you to the Audioconference on Wednesday, December 17, 2008 (1 p.m. Eastern time). There is no limit on the number of participants from your office, but the registration fee covers only one phone dial-in. Additional dial-ins require additional registration fees. For discount pricing on additional phone lines, please contact customer service at 800-521-4323. 3. You will also receive copies of the Printed Materials (in PDF format by e-mail). 4. Listen in to the Audioconference as you follow along with your Printed Materials. 5. The final segment of the Audioconference will let you ask questions and get answers about major changes ahead under President Obama that could impact the pharmaceutical regulatory landscape. 6. Cancellation Policy: To cancel your registration for this event and receive a full refund, you must contact customer service at 800-521-4323 no later than 48 hours prior to the scheduled start of the audioconference. Any cancellations received after dial in information and supplemental materials have been sent (48 hours prior to the start of the audioconference) will receive a CD of the audioconference or a credit valid for one year. Your credit (the cost of the audioconference) will be applied toward the purchase of any AIS product or audioconference. Can't make it on December 17? Order the CD or MP3 file and Printed Materials. Remember: A copyright release in the Printed Materials will permit you to make photocopies for each person listening to the Audioconference and/or recording.
Please note that CDs and MP3 files will be available within three weeks of the conference date. Audio CDs (and accompanying written materials) are shipped via UPS. Please give us your street address when you order (UPS does not deliver to PO boxes). You should receive your order within 5-7 business days.* Shipping cost is $5. MP3 files will be delivered as a download link within a PDF file of the accompanying written materials. Shipping will NOT be charged for this item.
Rush Orders: Please call us at 800-521-4323 to place a rush order.* We will overnight your order for an additional charge of $30, or you can give us your FedEx or UPS account number and we will charge the shipping to your account. Rush orders placed after 3:00pm EST will not be shipped out until the next business day. *CDs and MP3 files will be available within three weeks of the conference date.
Listeners will also receive practical written information to supplement information covered by the audioconference speakers.
For further information call 800-521-4323 or e-mail customerserv@aispub.com
|
|||||||||||||||||||||||||||||||||||||||||||
1100 17th Street, NW, Suite 300, Washington, DC 20036
Phone 202-775-9008 or 800-521-4323; E-mail customerserv@aispub.com